Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation

被引:65
作者
Lim, DS
Bae, KG
Jung, IS
Kim, CH
Yun, YS
Song, JY
机构
[1] Korea Canc Ctr Hosp, KAERL, Immunol Lab, Seoul 139706, South Korea
[2] KonKuk Univ, Anim Resources Res Ctr, Seoul 143701, South Korea
关键词
D O I
10.1053/jinf.2002.1007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the present research was conducted to elucidate anti-septicaemic effect of a polysaccharide (PS) isolated from Panax ginseng C.A. Meyer (Araliaceae) by nitric oxide production from stimulated macrophage. In vitro assays for the activity measurement of PS, NO production test with Greiss reagent, phagocytic activity test using zymosan and cytokines production test using ELISA kit were also conducted. In vivo anti-septicaemic activity was assessed by using C57BL/6J mice. This was done with Staphylococcus aureus infection test. PS used at 0.025 mg/kg concentration showed a potent anti-septicaemic activity (80%, survival). However, it did not directly inhibit S. aureus in a minimum inhibitory concentration (MIC) test, conducted in vitro (data not shown). Nitric oxide production via macrophage activation showed the highest value of 5.5 nmol/ml at 1 mug/ml PS. In in vitro phagocytic activity test, PS at 10 mug/ml concentration showed a potent phagocytic activity for zymosan with 167% of the control. Production of TNF-alpha by macrophage activation at 10 mug/ml of PS was 96% lysis of L929. Also production of IL-1 and IL-6 by stimulation of macrophage with 100 mug/ml PS dose increased to 235 pg/ml and 0.47 ng/ml. respectively. The low mortality of PS treated (0.025 mg/kg) infected mice was concurrent with decreased bacterial content in the blood. Nitric oxide production in S. aureus infected mice whose macrophage was stimulated by PS (0.025 mg/kg) increased approximately 4 times than the untreated S. aureus infected group at 24 and 48 h incubation. In the PS treated (0.025 mg/kg) group, the intracellular concentration of S. aureus in macrophages decreased approximately by 50%, compared with the untreated group. Combine treatment with PS (0.025 mg/kg body weight) and vancomycin (10 mg/kg B.W.) resulted in 100%, survival of the animals, whereas only 67% or 50% of the animals survived, respectively, when treated with PS or vancomycin alone. These results suggest that PS from Panax ginseng possess a potent anti-septicaemic activity by stimulating macrophage and a potentiality as an immunomodulator against sepsis occurred by Staphylococcus aureus. (C) 2002 The British Infection Society.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 28 条
[1]  
BECKERMAN KP, 1993, J IMMUNOL, V150, P888
[2]   Meningococcal disease as a model to evaluate novel anti-sepsis strategies [J].
Cohen, J .
CRITICAL CARE MEDICINE, 2000, 28 (09) :S64-S67
[3]   PHAGOCYTOSIS ENHANCES MURINE MACROPHAGE ACTIVATION BY INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
CORRADIN, SB ;
BUCHMULLERROUILLER, Y ;
MAUEL, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (10) :2553-2558
[5]   NITRIC-OXIDE SYNTHASE AND ANTIMICROBIAL ARMATURE OF HUMAN MACROPHAGES [J].
EIZIRIK, DL .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :744-745
[6]   COMPARISON OF INVITRO-CELL CYTO-TOXIC ASSAYS FOR TUMOR NECROSIS FACTOR [J].
FLICK, DA ;
GIFFORD, GE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 68 (1-2) :167-175
[7]   ACTIVATION OF MACROPHAGES FOR DESTRUCTION OF FRANCISELLA-TULARENSIS - IDENTIFICATION OF CYTOKINES, EFFECTOR-CELLS, AND EFFECTOR MOLECULES [J].
FORTIER, AH ;
POLSINELLI, T ;
GREEN, SJ ;
NACY, CA .
INFECTION AND IMMUNITY, 1992, 60 (03) :817-825
[8]  
GREEN SJ, 1993, CURR OPIN INFECT DIS, V6, P384
[9]   Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [J].
Hanaki, H ;
Kuwahara-Arai, K ;
Boyle-Vavra, S ;
Daum, RS ;
Labischinski, H ;
Hiramatsu, K .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :199-209
[10]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136